Kawuma Rachel, Seeley Janet, Mupambireyi Zivai, Cowan Frances, Bernays Sarah
a Medical Research Council/Uganda Virus Research Institute and London School of Hygiene & Tropical Medicine (MRC/UVRI and LSHTM) , Uganda Research Unit , Entebbe , Uganda.
b Global Health and Development Department , London School of Hygiene and Tropical Medicine , London , UK.
Afr J AIDS Res. 2018 Sep;17(3):217-225. doi: 10.2989/16085906.2018.1490785. Epub 2018 Aug 22.
We examined the logic that individuals use to account for delaying HIV testing and/or initiating HIV treatment. Our qualitative study, situated within the REALITY trial (Reduction of EArly mortaLITY in HIV infected adults and children starting antiretroviral therapy), was conducted in Uganda and Zimbabwe in 2015. Forty-eight participants (different age groups, sex and viral load/WHO disease stage) were included. Each participant had 2 interviews (1 after 4 weeks of participation in the trial the other after 12 weeks). If a person could manage presenting symptoms, they felt they had "more time" before starting antiretroviral therapy (ART). Their reluctance to have an HIV test (despite deteriorating health) arose from a belief that they were not "sick", that treatment was "not yet necessary". People in our study did not consider themselves as presenting "late", and treatment was not considered urgent as long as they considered their health to be "good enough".
我们研究了个体用于解释延迟进行艾滋病毒检测和/或开始艾滋病毒治疗的逻辑。我们的定性研究是在2015年于乌干达和津巴布韦进行的,该研究属于“艾滋病毒感染的成人和儿童开始抗逆转录病毒治疗后降低早期死亡率”(REALITY)试验。研究纳入了48名参与者(不同年龄组、性别以及病毒载量/世界卫生组织疾病阶段)。每位参与者接受了2次访谈(一次在参与试验4周后,另一次在12周后)。如果一个人能够控制当前症状,他们觉得在开始抗逆转录病毒治疗(ART)之前有“更多时间”。他们不愿进行艾滋病毒检测(尽管健康状况不断恶化)源于一种信念,即他们“没病”,治疗“还不必要”。我们研究中的人不认为自己就诊“晚”,并且只要他们认为自己的健康状况“足够好”,就不认为治疗是紧迫的。
J Acquir Immune Defic Syndr. 2021-11-1